Skip to main content
Premium Trial:

Request an Annual Quote

Matritech, Bruker Daltonics, NextGen, Michigan Core Technology Alliance, Syrrx


Matritech Awarded Patent for NMP Tech

Matritech said this week it has received a patent covering methods for detection of cancer using nuclear matrix proteins in bodily fluids such as blood and urine.

The patent, No. 6,740,494, covers technology that is used in the company’s diagnostic products for detection of bladder cancer, the company said.

Matritech, of Newton, Mass., has licensed this nuclear matrix protein technology exclusively from the Massachusetts Institute of Technology.

Bruker Daltonics Sells MALDI/TOF/TOF to New Zealand University

Bruker Daltonics has sold a MALDI-TOF/TOF instrument to Waikato University of Hamilton, New Zealand, for incorporation into a new center of excellence for mass spectrometry, the university said last week.

The instrument and associated sample handling robot have a value of NZ$800,000 (about $500,000), according to the university.

“Coupled with the equipment we already have at Waikato University, the addition of the MALDI-TOF/TOF will create a real center of excellence for mass spectrometry research and development,” Richard Price, Dean of Waikato University’s School of Science and Technology, said in a statement. “Together with other instrumentation in the School, we can offer a fully integrated facility for chemical and biological analysis, particularly in the specialist areas of genomics and proteomics.”

Bruker Daltonics’ New Zealand distributor is Bio-Strategy Distribution. Bruker said that the researchers at Waikato would be able to access other mass spec systems in Germany, the US, and Japan under a special collaborative deal with the company.

NextGen Awarded UK Patent

NextGen Sciences of Huntingdon, UK and Boston, said it has received a British patent for electrophoretic technology used in its 2DE system for automated gel electrophoresis.

The patent, ‘Electrophoretic Separation System’, number GB 2386954, covers the systems capability of performing iso-electric focusing with the separation medium on one face of a flexible plastic sheet, rather than the traditionaland cumbersome glass plates,” the company said.

It is the fourth patent granted to the company since its founding in 2000.

Michigan Alliance To Lease Equipment to Startups

The Michigan Core Technology Alliance — which includes Michigan Center for Structural Biology at Michigan State University and the Michigan Proteome Consortium at the University of Michigan — announced this week a new mandate allowing startups in the state to lease equipment from one of the alliance members.

The consortium did not disclose the fee structure for charging startups for use of the equipment, but said the effort was intended to help these companies to gain access to this equipment.

Syrrx Gets Milestone Payment from Biogen

Syrrx has received a milestone payment from Biogen Idec in a structural proteomics collaboration the companies started at the end of last year.

Under the agreement, which the companies announced this week, San Diego-based Syrrx has been performing high-throughput crystallization of proteins on several targets provided by Biogen.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.